PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Total Liabilities (2021 - 2026)

PepGen (PEPG) posted Total Liabilities of $22.3 million for Q1 2026, down 15.67% sequentially from $26.5 million in Q4 2025, and down 37.3% YoY from $35.6 million in Q1 2025.

Analysis

PepGen (PEPG) Total Liabilities (2021 - 2026) Analysis & Trends

PepGen has reported Total Liabilities for 6 years, with the latest figure at $22.3 million in Q1 2026.

  • Quarterly Total Liabilities fell 37.3% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.3 million (down 37.3% YoY) and the FY2025 annual result came in at $26.5 million, down 17.98% from the prior year.
  • Total Liabilities fell to $22.3 million in Q1 2026 per PEPG's latest filing, from $26.5 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $38.5 million in Q2 2024 and troughed at $15.5 million in Q3 2022.
  • A 5-year average of $29.9 million and a median of $32.3 million in 2024 frame the typical range for Total Liabilities.
  • The sharpest annual moves came in 2022 and 2026: Total Liabilities soared 258.48% in 2022, then tumbled 37.3% in 2026.
  • Over 5 years, Total Liabilities stood at $37.8 million in 2022, then decreased by 8.41% to $34.6 million in 2023, then retreated by 6.84% to $32.3 million in 2024, then declined by 17.98% to $26.5 million in 2025, then declined by 15.67% to $22.3 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $22.3 million, $26.5 million, and $26.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 PepGen 217.99 Mn 217.99 Mn - 21.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.86 Mn
Mar 31, 2026 22.32 Mn
Dec 31, 2025 26.46 Mn
Sep 30, 2025 26.92 Mn
Jun 30, 2025 31.08 Mn
Mar 31, 2025 35.59 Mn
Dec 31, 2024 32.26 Mn
Sep 30, 2024 32.78 Mn
Jun 30, 2024 38.47 Mn
Mar 31, 2024 28.00 Mn
Dec 31, 2023 34.63 Mn
Sep 30, 2023 38.41 Mn
Jun 30, 2023 34.80 Mn
Mar 31, 2023 36.20 Mn
Dec 31, 2022 37.81 Mn
Sep 30, 2022 15.52 Mn
Jun 30, 2022 20.58 Mn
Mar 31, 2022 16.29 Mn
Dec 31, 2021 10.55 Mn
Sep 30, 2021 25.61 Mn